Anthocyanins for Heart & Blood Vessels

The heart and blood vessels are where the anthocyanin evidence is strongest. Two very large observational studies — the Nurses' Health Study II and the British TwinsUK cohort — have linked higher anthocyanin intake, mostly from blueberries and strawberries, to a lower risk of heart attack, lower blood pressure, and less arterial stiffening. A handful of small-to-medium randomized trials feeding people whole blueberries or mixed berries have shown modest but real improvements in blood pressure, endothelial function, and HDL cholesterol. This page lays out what those studies actually found, the vascular mechanism behind them, and the important caveats: the population data cannot prove cause, the trials are mostly small and short, and nearly all of them used whole berries rather than isolated anthocyanins.

Table of Contents

  1. What Anthocyanins Do to Blood Vessels
  2. Endothelial Function and Nitric Oxide
  3. The Large Cohort Data: Heart Attack and Hypertension
  4. Blood Pressure: The Randomized Trials
  5. Arterial Stiffness
  6. LDL Oxidation, HDL, and Blood Lipids
  7. Metabolic Syndrome and Vascular Risk
  8. How Much, and From Which Foods
  9. The Honest Limits of the Evidence
  10. Key Research Papers
  11. External Resources
  12. Connections
  13. Featured Videos

What Anthocyanins Do to Blood Vessels

For years anthocyanins were described simply as "antioxidants" — molecules that neutralize free radicals. That framing is now considered incomplete and somewhat misleading, because the amount of intact anthocyanin that reaches the bloodstream is too small to make a meaningful dent in the body's total antioxidant capacity. The more current and better-supported view is that anthocyanins and, especially, the smaller phenolic-acid metabolites the body makes from them act as signaling molecules on the cells lining the blood vessels.

The single-cell-thick layer lining every artery and vein is the endothelium. A healthy endothelium relaxes the vessel on demand, resists the sticking of white blood cells and platelets, and keeps inflammation in check. When the endothelium becomes dysfunctional — an early, reversible step on the road to atherosclerosis — vessels stiffen, blood pressure rises, and plaque begins to form. Most of the cardiovascular benefits attributed to anthocyanins trace back to effects on this one tissue.

In laboratory and animal studies, cyanidin-3-glucoside (the most common dietary anthocyanin) and its metabolites have been shown to support endothelial nitric oxide production, reduce oxidative damage to LDL particles, and calm the inflammatory signaling (including NF-kappa-B activation) that drives plaque. Wallace's 2011 review in Advances in Nutrition catalogued these pathways and argued that anthocyanins influence cardiovascular disease through cell-signaling effects that go well beyond simple antioxidant chemistry. It is important to be clear that much of this mechanistic work is preclinical — done in cells and animals — and the human trials described below are what actually matter for deciding whether berries help people.

Back to Table of Contents

Endothelial Function and Nitric Oxide

Nitric oxide (NO) is the small gas molecule the endothelium releases to relax and widen an artery. Good NO signaling means flexible, responsive vessels; poor NO signaling means stiff, constricted ones. The most-studied way anthocyanins may help the heart is by supporting endothelial NO.

Mechanistic studies give a plausible picture. Wang and colleagues (2012, Journal of Nutrition) showed that cyanidin-3-glucoside protected the endothelium against damage in a model of high cholesterol, and Edwards and colleagues (2015) demonstrated that it is the phenolic-acid metabolites of anthocyanins — not the intact pigment — that modulate endothelial function at the low concentrations actually achievable in human blood. This fits the bioavailability data: since so little intact anthocyanin circulates, any real vascular effect almost has to come from its breakdown products.

In people, the clearest endothelial signal comes from Curtis and colleagues (2019), a six-month randomized trial in 115 adults with metabolic syndrome. A daily cup of blueberries improved flow-mediated dilation — the gold-standard ultrasound measure of endothelial function — and raised HDL-related markers. Woolf and colleagues (2023) found a similar flow-mediated-dilation improvement in postmenopausal women with above-normal blood pressure. These are encouraging, but note the honest wrinkle in the Curtis trial: the half-cup dose did not produce the same benefit, so the effect appears dose-dependent and not trivially easy to obtain.

Back to Table of Contents

The Large Cohort Data: Heart Attack and Hypertension

The most-cited anthocyanin findings come from enormous observational cohorts, where researchers estimate people's long-term anthocyanin intake from food questionnaires and then track who develops disease.

These numbers are large and consistent, which is why they get quoted so often. But they are associations. People who eat a lot of berries tend to differ in many ways from people who eat none — they may exercise more, smoke less, or eat better overall — and although the researchers statistically adjust for these, no adjustment is perfect. Cohort data of this kind is the reason to take anthocyanins seriously, not proof that a berry a day prevents a heart attack.

Back to Table of Contents

Blood Pressure: The Randomized Trials

Randomized controlled trials are what can actually establish cause and effect, and several small ones have tested berries on blood pressure with generally favorable, if modest, results:

A 5-mmHg reduction in systolic blood pressure is not trivial — at a population level a shift of that size meaningfully lowers stroke and heart-attack rates — but these are small studies of short duration, and the people most likely to benefit had elevated blood pressure to begin with. In normotensive people the effect is smaller and less certain. For the condition itself, see our page on Hypertension.

Back to Table of Contents

Arterial Stiffness

Arterial stiffness — how rigid or springy the large arteries are — is an independent predictor of cardiovascular events, often measured as pulse wave velocity. The TwinsUK analysis by Jennings and colleagues (2012) found that among about 1,900 women, those with higher habitual anthocyanin intake had lower central systolic blood pressure and less arterial stiffness. Because the study included identical twins, it offered some ability to account for shared genetics and upbringing, which strengthens the case a little compared with a standard cohort.

On the interventional side, the Johnson blueberry trial above reported improved arterial stiffness alongside the blood-pressure drop. The consistency between the observational stiffness finding and the small trial is reassuring, but again the trial evidence is limited to a handful of small studies, mostly in women, mostly using blueberries. Whether the same holds for men, for other berries, and over years rather than weeks has not been firmly established. Arterial stiffness matters because stiff arteries drive the vascular damage behind atherosclerosis and stroke.

Back to Table of Contents

LDL Oxidation, HDL, and Blood Lipids

Oxidized LDL cholesterol is more damaging to arteries than ordinary LDL, and anthocyanins have repeatedly been shown to reduce LDL oxidation in laboratory conditions. In humans the lipid effects are real but modest:

The practical takeaway is that berries are not a cholesterol-lowering drug. They may nudge the quality of your lipid profile in a favorable direction, particularly the oxidation status of LDL and the level of HDL, but if your LDL is high, anthocyanins are an adjunct to — not a replacement for — established dietary and, where indicated, pharmacologic management.

Back to Table of Contents

Metabolic Syndrome and Vascular Risk

Several of the strongest berry trials were done specifically in people with metabolic syndrome — the cluster of abdominal obesity, high blood pressure, high blood sugar, and abnormal lipids that dramatically raises cardiovascular risk. The Basu (2010) and Curtis (2019) trials both selected such participants, and both found favorable changes in vascular measures. This is meaningful because metabolic-syndrome patients are exactly the group with the most to gain from any improvement in endothelial function and blood pressure.

Anthocyanins may also modestly improve insulin sensitivity in this population, though the evidence is weaker and mixed. The mechanism would again route through the vasculature and through anti-inflammatory signaling rather than any direct blood-sugar-lowering action. If you have metabolic syndrome, berries are a sensible, low-risk addition to the core interventions that actually move the needle — weight management, physical activity, and reducing refined carbohydrate — but they are a supporting player. See Cardiovascular Disease and Coronary Artery Disease for the larger context.

Back to Table of Contents

How Much, and From Which Foods

The trials that showed benefit generally used the equivalent of one to two cups of blueberries per day, or about 150–200 g of mixed berries, providing very roughly a few hundred milligrams of anthocyanins daily. That is an achievable amount from whole food and a reasonable practical target.

For food-specific detail, see Blueberries, Raspberries, and Strawberries, and the companion Sources & Stability page.

Back to Table of Contents

The Honest Limits of the Evidence

Because this is where anthocyanin research is most often overstated, the caveats deserve their own section:

The bottom line: anthocyanin-rich berries are a genuinely healthy, low-risk food with real, if modest, cardiovascular support in controlled trials and impressive associations in large populations. That is a strong reason to eat them regularly — and not a reason to treat them as medicine.

Back to Table of Contents

Key Research Papers

  1. Cassidy A, et al. (2013). High anthocyanin intake is associated with a reduced risk of myocardial infarction in young and middle-aged women. Circulation. — PubMed 23319811
  2. Cassidy A, et al. (2011). Habitual intake of flavonoid subclasses and incident hypertension in adults. American Journal of Clinical Nutrition. — PubMed 21106916
  3. Jennings A, et al. (2012). Higher anthocyanin intake is associated with lower arterial stiffness and central blood pressure in women. American Journal of Clinical Nutrition. — PubMed 22914551
  4. Wallace TC (2011). Anthocyanins in cardiovascular disease. Advances in Nutrition. — PubMed 22211184
  5. Basu A, et al. (2010). Blueberries decrease cardiovascular risk factors in obese men and women with metabolic syndrome. Journal of Nutrition. — PubMed 20660279
  6. Erlund I, et al. (2008). Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol. American Journal of Clinical Nutrition. — PubMed 18258621
  7. Johnson SA, et al. (2015). Daily blueberry consumption improves blood pressure and arterial stiffness in postmenopausal women with pre- and stage 1-hypertension. Journal of the Academy of Nutrition and Dietetics. — PubMed 25578927
  8. Curtis PJ, et al. (2019). Blueberries improve biomarkers of cardiometabolic function in participants with metabolic syndrome. American Journal of Clinical Nutrition. — PubMed 31136659
  9. Woolf EK, et al. (2023). Daily blueberry consumption for 12 weeks improves endothelial function in postmenopausal women with above-normal blood pressure. Food & Function. — PubMed 36847333
  10. Wang Y, et al. (2012). Cyanidin-3-O-beta-glucoside protects against hypercholesterolemia-mediated endothelial dysfunction. Journal of Nutrition. — PubMed 22535762
  11. Edwards M, et al. (2015). Phenolic metabolites of anthocyanins modulate mechanisms of endothelial function. Journal of Agricultural and Food Chemistry. — PubMed 25686009

PubMed Topic Searches

  1. PubMed: Anthocyanins and endothelial function
  2. PubMed: Berry anthocyanins and blood pressure
  3. PubMed: Anthocyanin intake and cardiovascular disease
  4. PubMed: Blueberry and arterial stiffness
  5. PubMed: Anthocyanins and blood lipids

Back to Table of Contents

External Resources

Back to Table of Contents

Connections

Back to Table of Contents